Newbridge Financial Services Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Newbridge Financial Services Group’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.48K	Buy	+6,000	New	+$2.39K	﹤0.01%	1052
2024 Q3	–	Sell	-36,500	Closed	-$13.1K	–	1031
2024 Q2	$13.1K	Hold	36,500	–	–	﹤0.01%	657
2024 Q1	$24.5K	Buy	+36,500	New	+$26.5K	0.01%	556
2023 Q1	–	Sell	-2,000	Closed	-$6.28K	–	1468
2022 Q4	$6.28K	Hold	2,000	–	–	﹤0.01%	1018
2022 Q3	$10K	Sell	2,000 -1,000	-33%	-$5.14K	0.01%	889
2022 Q2	$12K	Buy	3,000 +1,500	+100%	+$6.49K	0.01%	819
2022 Q1	$9K	Hold	1,500	–	–	﹤0.01%	974
2021 Q4	$11K	Hold	1,500	–	–	0.01%	900
2021 Q3	$14K	Buy	+1,500	New	+$14.8K	0.01%	780

Other funds holding SGMO

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Newbridge Financial Services Group's SGMO Position: Q1 2026 in Review

Newbridge Financial Services Group opened a new position in SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026: 6,000 shares worth $1.48K. The stake represents ﹤0.01% of the portfolio and ranks #1052 among its holdings. This is a return to the name: Newbridge Financial Services Group previously reported a position in SGMO as recently as Q2 2024.

Newbridge Financial Services Group first reported a position in SGMO in Q3 2021 and has held it in 9 quarters since. The position peaked at $24.5K in Q1 2024. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

Newbridge Financial Services Group held 6,000 shares of SANGAMO THERAPEUTICS INC worth $1.48K as of Q1 2026.
SANGAMO THERAPEUTICS INC was a new Newbridge Financial Services Group position in Q1 2026.
SANGAMO THERAPEUTICS INC made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q1 2026, its #1052 holding.
Newbridge Financial Services Group first reported a position in SANGAMO THERAPEUTICS INC in Q3 2021 and has held it in 9 quarters since.
Newbridge Financial Services Group's SANGAMO THERAPEUTICS INC position peaked at $24.5K in Q1 2024.
112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.